FierceHealthcareFierceHealthITFierceHealthFinanceFierceEMRHospital ImpactFierceMobileHealthcare   FiercePharma

ALSO NOTED: States sue Abbott, claiming it blocked generics; SEC helps troubled hospital bond holders; and much more...

Tools
Tags
Abbott Laboratories
Centers for Disease Control and Prevention (CDC)
Tuberculosis
Drug Resistant Tuberculosis
Cancer Vaccine
TriCor
interest rate hikes

> Eighteen states are suing Abbott Laboratories, saying it blocked generic competition for its popular cholesterol medication TriCor. FiercePharma

> In an effort to help them avoid huge interest rate hikes due to auction failures, the SEC is allowing hospitals to bid on their own bonds. FierceHealthFinance

> The CDC has issued $38 million in grants to help health information exchanges deliver information to public health entities. FierceHealthIT

> It looks like this new cancer vaccine might be effective against cervical cancer. FierceVaccines

And Finally... A lack of adequate laboratory facilities in Asia and the Pacific is helping to fuel the spread of drug-resistant tuberculosis strains. Article

Bookmark and Share
Get Your FREE FierceHealthcare Email Newsletter:
Be the first to comment

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.